Skip to contentClarengateINTELLIGENCE
Companies/11439302

Medequip Holdings Limited

Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. · West Drayton

ActiveUnited KingdomIncorporated 2018Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · Company accounts

Net assets
£32,839,000
Cash
—
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
£16,336,000
Equity
£32,839,000
Average employees
Not available

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

2 periods

Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts

Reported figures2025-12-31Company · AI-read2024-12-31Company · AI-read
Balance sheet
Net assets£32,839,000£32,839,000
Equity£32,839,000£32,839,000
Share capital£890,000£890,000
Retained earnings−£1,487,000−£1,487,000
Assets
Investments£49,134,000£49,134,000
Debtors£41,000£41,000
Liabilities
Creditors within one year£16,336,000£16,336,000
Net current assets−£16,295,000−£16,295,000
Assets less current liabilities£32,839,000£32,839,000
Source evidenceView filing View filing

From the accounts

What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.

Audit
Subsidiary audit exemption, parent guarantee (s479A)
Immediate parent
Medux UK Holdco Limited
Ultimate parent
SHV Holdings N V
Ultimate controlling party
SHV Holdings N V
Accounts
Small company · FRS 102 Section 1A
Approved
2026-08-18, signed by S Harvey
Subsidiaries (5)
  • Medequip Group Limited · 100% · England & Wales · Holding Company
  • Siddall Medequip Limited · 100% · England & Wales · Dormant
  • Siddall Group Limited · 100% · England & Wales · Dormant
  • Medequip Assistive Technology Limited · 100% · England & Wales · Healthcare services
  • Manage at Home Limited · 100% · England & Wales · Dormant
Share classes (3)
  • 280,336 A ordinary shares of £1 each
  • 609,408 B ordinary shares of £1 each
  • 33,436,423 10% preferred ordinary shares of £0 00001 each
Events after the year end (1)
  • There were no events subsequent to the balance sheet date which would require additional disclosure.
Contingent liabilities (1)
  • The Company is an obligor to the committed facilities agreement put in place for the group of companies headed by Medux International B V. At 31 December 2025 the Medux International B V Group had utilised EUR221,700,000 on the facility total of EUR305,600,000.

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

1 outstanding charges
Fixed · created 2022-04-22
—
Outstanding
Show 2 satisfied / released
Fixed · created 2018-07-27 · satisfied 2022-04-11
—
Satisfied
All Assets · created 2018-07-27 · satisfied 2022-04-11
—
Satisfied